Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease

Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of ^99mTc-TRODAT-1 SPECT to detect Parkinson's disease

Ann Nucl Med. 2020 Jan;34(1):38. doi: 10.1007/s12149-019-01434-w.

¹ Department of Nuclear Medicine, Huashan Hospital, Fudan University, No. 12 Wulumuqi Middle Road, Jing'an District, Shanghai, 200040, China.
² Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, No. 20 Qianrong Road, Binhu District, Wuxi, 214063, Jiangsu, China.
³ Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiaotong University, No. 197, Ruijin Er Road, Shanghai, 200025, China.
⁴ Department of Nuclear Medicine, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301 Yangchang Middle Road, Jing'an District, Shanghai, 200072, China.
⁵ Universal Medical Imaging Diagnostic Center, No. 406 Guilin Road, Xuhui District, Shanghai, 200233, China. 1436150464@qq.com.
⁶ Department of Nuclear Medicine, Huashan Hospital, Fudan University, No. 12 Wulumuqi Middle Road, Jing'an District, Shanghai, 200040, China. xingdliu@fudan.edu.cn.

The corresponding author of the article would like to remove "Jian Wang" in the author group.